1. Signaling Pathways
  2. Others
  3. Drug Intermediate

Drug Intermediate

Drug Iintermediate

 

Drug Intermediate Related Products (199):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-128922
    Dexamethasone palmitate
    99.68%
    Dexamethasone palmitate (DXP) is a proagent of Dexamethasone (HY-14648). Dexamethasone palmitate can be used for the research of inflammation.
    Dexamethasone palmitate
  • HY-111895A
    Macropa-NH2 hydrochloride
    99.51%
    Macropa-NH2 hydrochloride is the precursor of Macropa-NCS. Macropa-NCS is conjugated to Anti-Human HER2 (HY-P9907) as well as to the prostate-specific membrane antigen-targeting compound RPS-070 and is a promising therapeutic radionuclide applied in the treatment of soft-tissue metastases.
    Macropa-NH2 hydrochloride
  • HY-120947
    AV-105
    99.70%
    AV-105 is a Florbetapir (18F)-radiolabeled slyrylpyridine tosylate precursor extracted from patent WO2010078370A1, example 1.5. AV-105 can synthesize 18F-radiolabeled compounds, which are used for positron emission tomography (PET) imaging of neurodegenerative diseases of the brain.
    AV-105
  • HY-135140
    Methyltetrazine-Amine
    98.02%
    Methyltetrazine-Amine, a tetrazine compound, is used for the site-specific dual functionalization of the resulting bioconjugates.
    Methyltetrazine-Amine
  • HY-30236
    5-Bromoindole
    99.97%
    5-Bromoindole is a chemical intermediate that can be used for the synthesis of GSK-3 inhibitors and anti-cancer agents.
    5-Bromoindole
  • HY-75095
    (S)-(-)-1-Phenylethanamine
    (S)-(-)-1-Phenylethanamine (S-(-)-α-Phenylethylamine; L-(-)-α-Methylbenzylamine) is a S-isomer of 1-Phenylethanamine (HY-W012848). 1-Phenylethanamine is a potential central nervous system stimulant and can be used to synthesize the tyrosine kinase inhibitor CLM3 (HY-164413).
    (S)-(-)-1-Phenylethanamine
  • HY-W098322
    Z-Lys-OMe hydrochloride
    Control
    Z-Lys-OMe hydrochloride is a synthetic intermediate that can be used in the synthesis of peptide enzyme substrates and lysine cationic surfactants.
    Z-Lys-OMe hydrochloride
  • HY-W016456
    5-Bromopentanoic acid
    5-Bromopentanoic acid can be used for the synthesis of inhibitors for aminoglycoside resistant bacteria.
    5-Bromopentanoic acid
  • HY-N9960
    α-Isopropylmalate
    ≥98.0%
    α-Isopropylmalate (α-IPM) is the leucine biosynthetic precursor in Yeast.
    α-Isopropylmalate
  • HY-N0348
    Dexamethasone 9,11-epoxide
    99.30%
    Dexamethasone 9,11-epoxide, a compound extracted from patent CN 106520896 A and RU 2532902 C1, is an intermediate in the preparation of dexamethasone.
    Dexamethasone 9,11-epoxide
  • HY-147012
    GalNAc-L96
    GalNAc-L96 is a triantennary GalNAc ligand that can be used for the synthesis of GalNAc-siRNA. GalNAc is a ligand of ASGPR (asialoglycoprotein receptor).
    GalNAc-L96
  • HY-W038985
    1,3-Oxazolidine-2-thione
    99.67%
    1,3-Oxazolidine-2-thione, a free oxazolidinethione, increases thyroid size and severely depresses hepatic trimethylamine oxidase activity in the brown-egg layers.
    1,3-Oxazolidine-2-thione
  • HY-W017378
    Trimethylhydroquinone
    99.75%
    Trimethylhydroquinone is a key intermediate for the synthesis of Vitamin E or other trimethylhydroquinone derivatives with antioxidative effects.
    Trimethylhydroquinone
  • HY-B1079
    Suxibuzone
    99.74%
    Suxibuzone is a compound used for the study of joint and muscle pain, and it is a prodrug of the non-steroidal anti-inflammatory drug Phenylbutazone.
    Suxibuzone
  • HY-W040233B
    Sodium (S)-2-hydroxypropanoate (purity≥90%)
    ≥98.0%
    Sodium (S)-2-hydroxypropanoate (Sodium L-lactate) (purity≥90%) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.
    Sodium (S)-2-hydroxypropanoate (purity≥90%)
  • HY-W007977
    4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
    4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline (Compound 11 and 15) is a building block and synthetic intermediate, which can be used as a precursor in the synthesis of receptor tyrosine kinase (RTK) inhibitors, dual RTK and histone deacetylase (HDAC) inhibitors, and anticancer agents. 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline can also be used to synthesize EGFR inhibitors, including Erlotinib (HY-50896), with antiproliferative activity.
    4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
  • HY-114771
    α-Truxillic acid
    99.87%
    α-Truxillic acid is form by the dimerization of two molecules of α-trans-cinnamic acid, with anti-inflammatory activities.
    α-Truxillic acid
  • HY-79722
    4-trans-Hydroxycyclohexylamine
    99.82%
    4-trans-Hydroxycyclohexylamine (trans-4-Aminocyclohexan-1-ol) is a raw material in organic synthesis.
    4-trans-Hydroxycyclohexylamine
  • HY-B1629
    Dichlorodiphenylmethane
    Dichlorodiphenylmethane is a drug intermediate, which is widely used in the fields of pesticide, dye and medicine.
    Dichlorodiphenylmethane
  • HY-Y0109
    Chloropyrazine
    99.70%
    Chloropyrazine (Pyrazin-2-yl chloride) is a member of pyrazines, can be used for the synthesis of active compounds.
    Chloropyrazine